The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Thrombin-Global Market Insights and Sales Trends 2025
Synopsis
Thrombin is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.
The global Thrombin market size is expected to reach US$ 704.7 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Thrombin in various end use industries. The expanding demands from the Hospitals, Diagnostics & Clinics and Academic and Research Institute,, are propelling Thrombin market. Powder Form, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Solution Form segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Thrombin market, driven by demand from China, the second largest economy with some signs of stabilising, the Thrombin market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thrombin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thrombin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thrombin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thrombin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thrombin covered in this report include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer and Octapharma, etc.
The global Thrombin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Global Thrombin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thrombin market, Segment by Type:
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Global Thrombin market, by Application
Hospitals
Diagnostics & Clinics
Academic and Research Institute
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Thrombin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Thrombin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Thrombin is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.
The global Thrombin market size is expected to reach US$ 704.7 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Thrombin in various end use industries. The expanding demands from the Hospitals, Diagnostics & Clinics and Academic and Research Institute,, are propelling Thrombin market. Powder Form, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Solution Form segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Thrombin market, driven by demand from China, the second largest economy with some signs of stabilising, the Thrombin market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thrombin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thrombin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thrombin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thrombin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thrombin covered in this report include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer and Octapharma, etc.
The global Thrombin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Global Thrombin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thrombin market, Segment by Type:
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Global Thrombin market, by Application
Hospitals
Diagnostics & Clinics
Academic and Research Institute
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Thrombin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Thrombin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Thrombin Market Overview
1.1 Thrombin Product Overview
1.2 Thrombin Market Segment by Type
1.2.1 Powder Form
1.2.2 Solution Form
1.2.3 Pad Form
1.2.4 Spray Kits
1.2.5 Others
1.3 Global Thrombin Market Size by Type
1.3.1 Global Thrombin Market Size Overview by Type (2018-2029)
1.3.2 Global Thrombin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Thrombin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Thrombin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Thrombin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Thrombin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Thrombin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Thrombin Sales Breakdown by Type (2018-2023)
2 Global Thrombin Market Competition by Company
2.1 Global Top Players by Thrombin Sales (2018-2023)
2.2 Global Top Players by Thrombin Revenue (2018-2023)
2.3 Global Top Players by Thrombin Price (2018-2023)
2.4 Global Top Manufacturers Thrombin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Thrombin Market Competitive Situation and Trends
2.5.1 Thrombin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Thrombin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thrombin as of 2022)
2.7 Date of Key Manufacturers Enter into Thrombin Market
2.8 Key Manufacturers Thrombin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Thrombin Status and Outlook by Region
3.1 Global Thrombin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Thrombin Historic Market Size by Region
3.2.1 Global Thrombin Sales in Volume by Region (2018-2023)
3.2.2 Global Thrombin Sales in Value by Region (2018-2023)
3.2.3 Global Thrombin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Thrombin Forecasted Market Size by Region
3.3.1 Global Thrombin Sales in Volume by Region (2024-2029)
3.3.2 Global Thrombin Sales in Value by Region (2024-2029)
3.3.3 Global Thrombin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Thrombin by Application
4.1 Thrombin Market Segment by Application
4.1.1 Hospitals
4.1.2 Diagnostics & Clinics
4.1.3 Academic and Research Institute
4.2 Global Thrombin Market Size by Application
4.2.1 Global Thrombin Market Size Overview by Application (2018-2029)
4.2.2 Global Thrombin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Thrombin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Thrombin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Thrombin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Thrombin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Thrombin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Thrombin Sales Breakdown by Application (2018-2023)
5 North America Thrombin by Country
5.1 North America Thrombin Historic Market Size by Country
5.1.1 North America Thrombin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Thrombin Sales in Volume by Country (2018-2023)
5.1.3 North America Thrombin Sales in Value by Country (2018-2023)
5.2 North America Thrombin Forecasted Market Size by Country
5.2.1 North America Thrombin Sales in Volume by Country (2024-2029)
5.2.2 North America Thrombin Sales in Value by Country (2024-2029)
6 Europe Thrombin by Country
6.1 Europe Thrombin Historic Market Size by Country
6.1.1 Europe Thrombin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Thrombin Sales in Volume by Country (2018-2023)
6.1.3 Europe Thrombin Sales in Value by Country (2018-2023)
6.2 Europe Thrombin Forecasted Market Size by Country
6.2.1 Europe Thrombin Sales in Volume by Country (2024-2029)
6.2.2 Europe Thrombin Sales in Value by Country (2024-2029)
7 Asia-Pacific Thrombin by Region
7.1 Asia-Pacific Thrombin Historic Market Size by Region
7.1.1 Asia-Pacific Thrombin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Thrombin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Thrombin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Thrombin Forecasted Market Size by Region
7.2.1 Asia-Pacific Thrombin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Thrombin Sales in Value by Region (2024-2029)
8 Latin America Thrombin by Country
8.1 Latin America Thrombin Historic Market Size by Country
8.1.1 Latin America Thrombin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Thrombin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Thrombin Sales in Value by Country (2018-2023)
8.2 Latin America Thrombin Forecasted Market Size by Country
8.2.1 Latin America Thrombin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Thrombin Sales in Value by Country (2024-2029)
9 Middle East and Africa Thrombin by Country
9.1 Middle East and Africa Thrombin Historic Market Size by Country
9.1.1 Middle East and Africa Thrombin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Thrombin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Thrombin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Thrombin Forecasted Market Size by Country
9.2.1 Middle East and Africa Thrombin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Thrombin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Thrombin Products Offered
10.1.5 Takeda Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer Thrombin Products Offered
10.2.5 Bayer Recent Development
10.3 CSL
10.3.1 CSL Company Information
10.3.2 CSL Introduction and Business Overview
10.3.3 CSL Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CSL Thrombin Products Offered
10.3.5 CSL Recent Development
10.4 Grifols
10.4.1 Grifols Company Information
10.4.2 Grifols Introduction and Business Overview
10.4.3 Grifols Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Grifols Thrombin Products Offered
10.4.5 Grifols Recent Development
10.5 GE Healthcare
10.5.1 GE Healthcare Company Information
10.5.2 GE Healthcare Introduction and Business Overview
10.5.3 GE Healthcare Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GE Healthcare Thrombin Products Offered
10.5.5 GE Healthcare Recent Development
10.6 Hualan Biological
10.6.1 Hualan Biological Company Information
10.6.2 Hualan Biological Introduction and Business Overview
10.6.3 Hualan Biological Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Hualan Biological Thrombin Products Offered
10.6.5 Hualan Biological Recent Development
10.7 Haematologic Technologies Inc.
10.7.1 Haematologic Technologies Inc. Company Information
10.7.2 Haematologic Technologies Inc. Introduction and Business Overview
10.7.3 Haematologic Technologies Inc. Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Haematologic Technologies Inc. Thrombin Products Offered
10.7.5 Haematologic Technologies Inc. Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Thrombin Products Offered
10.8.5 Pfizer Recent Development
10.9 Octapharma
10.9.1 Octapharma Company Information
10.9.2 Octapharma Introduction and Business Overview
10.9.3 Octapharma Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Octapharma Thrombin Products Offered
10.9.5 Octapharma Recent Development
10.10 Omrix Biopharmaceuticals Ltd.
10.10.1 Omrix Biopharmaceuticals Ltd. Company Information
10.10.2 Omrix Biopharmaceuticals Ltd. Introduction and Business Overview
10.10.3 Omrix Biopharmaceuticals Ltd. Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Omrix Biopharmaceuticals Ltd. Thrombin Products Offered
10.10.5 Omrix Biopharmaceuticals Ltd. Recent Development
10.11 Shanghai RAAS
10.11.1 Shanghai RAAS Company Information
10.11.2 Shanghai RAAS Introduction and Business Overview
10.11.3 Shanghai RAAS Thrombin Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Shanghai RAAS Thrombin Products Offered
10.11.5 Shanghai RAAS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Thrombin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Thrombin Industrial Chain Analysis
11.4 Thrombin Market Dynamics
11.4.1 Thrombin Industry Trends
11.4.2 Thrombin Market Drivers
11.4.3 Thrombin Market Challenges
11.4.4 Thrombin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Thrombin Distributors
12.3 Thrombin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
